Global Cancer Therapy and Testing Market Growth (Status and Outlook) 2024-2030

2024

Global Cancer Therapy and Testing Market Growth (Status and Outlook) 2024-2030

Name: Global Cancer Therapy and Testing Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001372
Price: 3450 USD
Availability: InStock
Rating: 4 (10.1 reviews)

The global cancer therapy and testing market is rapidly evolving with significant growth in the prevention, diagnosis, and treatment of cancer.

Bonafide Trust
21-08-2024
Pages : 128
Figures : 81
Tables : 125
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global cancer therapy and testing market is a rapidly evolving sector within the healthcare industry, dedicated to the prevention, diagnosis, and treatment of cancer. This market encompasses a wide range of products and services, including cancer diagnostics (such as imaging, biopsies, and liquid biopsies), cancer treatments (such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy), and supportive care. The rising global incidence of cancer, driven by factors such as aging populations, lifestyle changes, and environmental factors, is a primary driver of market growth. Governments and organizations worldwide are increasingly investing in cancer research and awareness initiatives, further propelling the demand for advanced cancer therapies and diagnostic tools. Technological advancements, particularly in personalized medicine and immunotherapy, are improving treatment effectiveness and patient outcomes, leading to increased adoption of these innovative therapies. Additionally, significant funding from pharmaceutical companies and favorable governmental policies are fostering advancements in drug discovery and development. The expanding patient population and enhanced healthcare systems in developing nations also contribute positively to market expansion. Partnerships between biotechnology companies and research organizations are enriching the development pipeline for new therapies, highlighting the evolving landscape of the oncology arena. This complex scenario underpins ongoing growth and progress within the field, ensuring that the global cancer therapy and testing market continues to play a crucial role in improving cancer care and patient outcomes worldwide.

The global Cancer Therapy and Testing market size is projected to grow from US$ 684780 million in 2023 to US$ 1670770 million in 2030; it is expected to grow at a CAGR of 13.6% from 2024 to 2030. Two significant market drivers of the global cancer therapy and testing market are the rising global incidence of cancer and technological advancements in diagnostics and treatment. Firstly, the rising global incidence of cancer is a major driver of market growth. Factors such as aging populations, lifestyle changes, and environmental influences have led to an increase in cancer cases worldwide. This growing patient population necessitates more advanced and effective cancer therapies and diagnostic tools, driving demand in the market. Governments and organizations are also investing heavily in cancer research and awareness initiatives, further propelling the market's expansion. Secondly, technological advancements in diagnostics and treatment are significantly contributing to market growth. Innovations in personalized medicine, immunotherapy, and liquid biopsies are improving treatment effectiveness and patient outcomes. These advancements enable more accurate and less invasive diagnostic methods, enhancing early detection and targeted treatment strategies. The development of new therapies and diagnostic tools, supported by substantial funding from pharmaceutical companies and favorable government policies, is fostering continuous progress in the field.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global cancer therapy and testing market is segmented by type into several key categories, including cancer diagnostics and cancer treatments. Cancer diagnostics encompass a range of tests and procedures used to detect and diagnose cancer, such as imaging (e.g., MRI, CT scans), biopsies (e.g., tissue biopsy, liquid biopsy), and biomarker tests (e.g., tumor marker tests, immunohistochemistry). These diagnostic tools are crucial for early detection and accurate diagnosis, enabling timely and effective treatment. Cancer treatments include various therapeutic approaches, such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. Chemotherapy uses drugs to kill cancer cells or stop them from growing, while targeted therapy focuses on specific molecules involved in cancer growth. Immunotherapy boosts the body's immune system to fight cancer, and hormonal therapy targets hormone receptors to slow or stop the growth of certain cancers. Each type of treatment plays a vital role in managing different types of cancer, contributing to the overall effectiveness of cancer care. The continuous advancements in both diagnostics and treatments are driving the growth of the global cancer therapy and testing market, as they improve patient outcomes and offer more personalized and precise treatment options. This segmentation highlights the diverse and comprehensive nature of the market, reflecting the ongoing efforts to enhance cancer diagnosis and treatment.

The global cancer therapy and testing market, segmented by application, encompasses a wide range of areas where cancer diagnostics and treatments are utilized. Hospitals and specialty clinics are primary end users, providing comprehensive cancer care, including diagnosis, treatment, and follow-up care. These institutions rely on advanced diagnostic tools like imaging, biopsies, and biomarker tests to detect cancer early and accurately. Cancer and radiation therapy centers focus on delivering specialized treatments such as chemotherapy, targeted therapy, immunotherapy, and radiation therapy. These centers are equipped with state-of-the-art technology and expertise to administer complex cancer treatments. Research institutions and pharmaceutical companies play a crucial role in developing new therapies and diagnostic tools, driving innovation in the field. Their efforts in clinical trials and drug development contribute to the advancement of cancer care. Government and non-governmental organizations support cancer awareness programs, patient assistance initiatives, and funding for research, enhancing access to cancer care and promoting early detection. Home healthcare services are also becoming increasingly important, providing patients with the convenience of receiving treatment and monitoring in the comfort of their homes. This application segment highlights the diverse and collaborative efforts across various sectors to improve cancer diagnosis and treatment, ultimately aiming to enhance patient outcomes and quality of life.

The regional analysis of the global cancer therapy and testing market reveals distinct trends and growth patterns across different geographical areas, highlighting its critical role in supporting regional industrial and economic development. The Asia-Pacific region stands out as the dominant player, contributing over 50% of the market share, driven by rapid industrialization, urbanization, and extensive infrastructure development in countries like China, India, and South Korea. China's position as the world's largest producer and consumer of steel significantly bolsters this dominance. In North America, steady demand is primarily driven by the construction and automotive sectors, with the U.S. government's focus on revitalizing domestic manufacturing and infrastructure development programs enhancing the market. However, the region faces challenges such as fluctuating raw material prices and geopolitical tensions affecting supply chains. The European market is notable for its emphasis on sustainable construction practices and advanced steel technologies, with significant contributions from countries like Germany, France, and the U.K. Despite stringent environmental regulations, the need for continuous innovation drives market growth. Emerging markets in the Middle East, Africa, and Latin America are experiencing growth due to increasing infrastructure projects and industrial activities, presenting opportunities for expansion as governments invest in modernizing infrastructure and boosting economic development.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Therapy and Testing Market Size 2019-2030
2.1.2 Cancer Therapy and Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Therapy and Testing Segment by Type
2.2.1 Cancer Detection
2.2.2 Cancer Treatment
2.3 Cancer Therapy and Testing Market Size by Type
2.3.1 Cancer Therapy and Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
2.4 Cancer Therapy and Testing Segment by Application
2.4.1 Lung Cancer
2.4.2 Rectal Cancer
2.4.3 Breast Cancer
2.4.4 Other
2.5 Cancer Therapy and Testing Market Size by Application
2.5.1 Cancer Therapy and Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
3 Cancer Therapy and Testing Market Size by Player
3.1 Cancer Therapy and Testing Market Size Market Share by Players
3.1.1 Global Cancer Therapy and Testing Revenue by Players (2019-2024)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Therapy and Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cancer Therapy and Testing by Regions
4.1 Cancer Therapy and Testing Market Size by Regions (2019-2024)
4.2 Americas Cancer Therapy and Testing Market Size Growth (2019-2024)
4.3 APAC Cancer Therapy and Testing Market Size Growth (2019-2024)
4.4 Europe Cancer Therapy and Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Therapy and Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cancer Therapy and Testing Market Size by Country (2019-2024)
5.2 Americas Cancer Therapy and Testing Market Size by Type (2019-2024)
5.3 Americas Cancer Therapy and Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Therapy and Testing Market Size by Region (2019-2024)
6.2 APAC Cancer Therapy and Testing Market Size by Type (2019-2024)
6.3 APAC Cancer Therapy and Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cancer Therapy and Testing by Country (2019-2024)
7.2 Europe Cancer Therapy and Testing Market Size by Type (2019-2024)
7.3 Europe Cancer Therapy and Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cancer Therapy and Testing by Region (2019-2024)
8.2 Middle East & Africa Cancer Therapy and Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Therapy and Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cancer Therapy and Testing Market Forecast
10.1 Global Cancer Therapy and Testing Forecast by Regions (2025-2030)
10.1.1 Global Cancer Therapy and Testing Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Therapy and Testing Forecast
10.1.3 APAC Cancer Therapy and Testing Forecast
10.1.4 Europe Cancer Therapy and Testing Forecast
10.1.5 Middle East & Africa Cancer Therapy and Testing Forecast
10.2 Americas Cancer Therapy and Testing Forecast by Country (2025-2030)
10.2.1 United States Cancer Therapy and Testing Market Forecast
10.2.2 Canada Cancer Therapy and Testing Market Forecast
10.2.3 Mexico Cancer Therapy and Testing Market Forecast
10.2.4 Brazil Cancer Therapy and Testing Market Forecast
10.3 APAC Cancer Therapy and Testing Forecast by Region (2025-2030)
10.3.1 China Cancer Therapy and Testing Market Forecast
10.3.2 Japan Cancer Therapy and Testing Market Forecast
10.3.3 Korea Cancer Therapy and Testing Market Forecast
10.3.4 Southeast Asia Cancer Therapy and Testing Market Forecast
10.3.5 India Cancer Therapy and Testing Market Forecast
10.3.6 Australia Cancer Therapy and Testing Market Forecast
10.4 Europe Cancer Therapy and Testing Forecast by Country (2025-2030)
10.4.1 Germany Cancer Therapy and Testing Market Forecast
10.4.2 France Cancer Therapy and Testing Market Forecast
10.4.3 UK Cancer Therapy and Testing Market Forecast
10.4.4 Italy Cancer Therapy and Testing Market Forecast
10.4.5 Russia Cancer Therapy and Testing Market Forecast
10.5 Middle East & Africa Cancer Therapy and Testing Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Therapy and Testing Market Forecast
10.5.2 South Africa Cancer Therapy and Testing Market Forecast
10.5.3 Israel Cancer Therapy and Testing Market Forecast
10.5.4 Turkey Cancer Therapy and Testing Market Forecast
10.5.5 GCC Countries Cancer Therapy and Testing Market Forecast
10.6 Global Cancer Therapy and Testing Forecast by Type (2025-2030)
10.7 Global Cancer Therapy and Testing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Invitae
11.1.1 Invitae Company Information
11.1.2 Invitae Cancer Therapy and Testing Product Offered
11.1.3 Invitae Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Invitae Main Business Overview
11.1.5 Invitae Latest Developments
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Information
11.2.2 Foundation Medicine Cancer Therapy and Testing Product Offered
11.2.3 Foundation Medicine Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Foundation Medicine Main Business Overview
11.2.5 Foundation Medicine Latest Developments
11.3 Guardant Health
11.3.1 Guardant Health Company Information
11.3.2 Guardant Health Cancer Therapy and Testing Product Offered
11.3.3 Guardant Health Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Guardant Health Main Business Overview
11.3.5 Guardant Health Latest Developments
11.4 Illumina
11.4.1 Illumina Company Information
11.4.2 Illumina Cancer Therapy and Testing Product Offered
11.4.3 Illumina Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Illumina Main Business Overview
11.4.5 Illumina Latest Developments
11.5 Sysmex
11.5.1 Sysmex Company Information
11.5.2 Sysmex Cancer Therapy and Testing Product Offered
11.5.3 Sysmex Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sysmex Main Business Overview
11.5.5 Sysmex Latest Developments
11.6 Abingdon Health
11.6.1 Abingdon Health Company Information
11.6.2 Abingdon Health Cancer Therapy and Testing Product Offered
11.6.3 Abingdon Health Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abingdon Health Main Business Overview
11.6.5 Abingdon Health Latest Developments
11.7 Sophia
11.7.1 Sophia Company Information
11.7.2 Sophia Cancer Therapy and Testing Product Offered
11.7.3 Sophia Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sophia Main Business Overview
11.7.5 Sophia Latest Developments
11.8 NanoEntek
11.8.1 NanoEntek Company Information
11.8.2 NanoEntek Cancer Therapy and Testing Product Offered
11.8.3 NanoEntek Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NanoEntek Main Business Overview
11.8.5 NanoEntek Latest Developments
11.9 BGI
11.9.1 BGI Company Information
11.9.2 BGI Cancer Therapy and Testing Product Offered
11.9.3 BGI Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BGI Main Business Overview
11.9.5 BGI Latest Developments
11.10 Diagnosis
11.10.1 Diagnosis Company Information
11.10.2 Diagnosis Cancer Therapy and Testing Product Offered
11.10.3 Diagnosis Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Diagnosis Main Business Overview
11.10.5 Diagnosis Latest Developments
11.11 Exact Sciences
11.11.1 Exact Sciences Company Information
11.11.2 Exact Sciences Cancer Therapy and Testing Product Offered
11.11.3 Exact Sciences Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Exact Sciences Main Business Overview
11.11.5 Exact Sciences Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Cancer Therapy and Testing Product Offered
11.12.3 AstraZeneca Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Bayer AG
11.13.1 Bayer AG Company Information
11.13.2 Bayer AG Cancer Therapy and Testing Product Offered
11.13.3 Bayer AG Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bayer AG Main Business Overview
11.13.5 Bayer AG Latest Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Information
11.14.2 Johnson & Johnson Cancer Therapy and Testing Product Offered
11.14.3 Johnson & Johnson Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Johnson & Johnson Main Business Overview
11.14.5 Johnson & Johnson Latest Developments
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Information
11.15.2 Pfizer Inc. Cancer Therapy and Testing Product Offered
11.15.3 Pfizer Inc. Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pfizer Inc. Main Business Overview
11.15.5 Pfizer Inc. Latest Developments
12 Research Findings and Conclusion

Table 1. Cancer Therapy and Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Cancer Detection
Table 3. Major Players of Cancer Treatment
Table 4. Cancer Therapy and Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Cancer Therapy and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Table 7. Cancer Therapy and Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Cancer Therapy and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Table 10. Global Cancer Therapy and Testing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Cancer Therapy and Testing Revenue Market Share by Player (2019-2024)
Table 12. Cancer Therapy and Testing Key Players Head office and Products Offered
Table 13. Cancer Therapy and Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Cancer Therapy and Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Cancer Therapy and Testing Market Size Market Share by Regions (2019-2024)
Table 18. Global Cancer Therapy and Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Cancer Therapy and Testing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Cancer Therapy and Testing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Cancer Therapy and Testing Market Size Market Share by Country (2019-2024)
Table 22. Americas Cancer Therapy and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Table 24. Americas Cancer Therapy and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Table 26. APAC Cancer Therapy and Testing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Cancer Therapy and Testing Market Size Market Share by Region (2019-2024)
Table 28. APAC Cancer Therapy and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Table 30. APAC Cancer Therapy and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Table 32. Europe Cancer Therapy and Testing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Cancer Therapy and Testing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cancer Therapy and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Table 36. Europe Cancer Therapy and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Cancer Therapy and Testing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Cancer Therapy and Testing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Cancer Therapy and Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Cancer Therapy and Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Therapy and Testing
Table 45. Key Market Challenges & Risks of Cancer Therapy and Testing
Table 46. Key Industry Trends of Cancer Therapy and Testing
Table 47. Global Cancer Therapy and Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Cancer Therapy and Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Cancer Therapy and Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Cancer Therapy and Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Invitae Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 52. Invitae Cancer Therapy and Testing Product Offered
Table 53. Invitae Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Invitae Main Business
Table 55. Invitae Latest Developments
Table 56. Foundation Medicine Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 57. Foundation Medicine Cancer Therapy and Testing Product Offered
Table 58. Foundation Medicine Main Business
Table 59. Foundation Medicine Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Foundation Medicine Latest Developments
Table 61. Guardant Health Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 62. Guardant Health Cancer Therapy and Testing Product Offered
Table 63. Guardant Health Main Business
Table 64. Guardant Health Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Guardant Health Latest Developments
Table 66. Illumina Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 67. Illumina Cancer Therapy and Testing Product Offered
Table 68. Illumina Main Business
Table 69. Illumina Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Illumina Latest Developments
Table 71. Sysmex Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 72. Sysmex Cancer Therapy and Testing Product Offered
Table 73. Sysmex Main Business
Table 74. Sysmex Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sysmex Latest Developments
Table 76. Abingdon Health Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 77. Abingdon Health Cancer Therapy and Testing Product Offered
Table 78. Abingdon Health Main Business
Table 79. Abingdon Health Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Abingdon Health Latest Developments
Table 81. Sophia Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 82. Sophia Cancer Therapy and Testing Product Offered
Table 83. Sophia Main Business
Table 84. Sophia Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Sophia Latest Developments
Table 86. NanoEntek Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 87. NanoEntek Cancer Therapy and Testing Product Offered
Table 88. NanoEntek Main Business
Table 89. NanoEntek Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. NanoEntek Latest Developments
Table 91. BGI Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 92. BGI Cancer Therapy and Testing Product Offered
Table 93. BGI Main Business
Table 94. BGI Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. BGI Latest Developments
Table 96. Diagnosis Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 97. Diagnosis Cancer Therapy and Testing Product Offered
Table 98. Diagnosis Main Business
Table 99. Diagnosis Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Diagnosis Latest Developments
Table 101. Exact Sciences Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 102. Exact Sciences Cancer Therapy and Testing Product Offered
Table 103. Exact Sciences Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Exact Sciences Main Business
Table 105. Exact Sciences Latest Developments
Table 106. AstraZeneca Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 107. AstraZeneca Cancer Therapy and Testing Product Offered
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. AstraZeneca Latest Developments
Table 111. Bayer AG Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 112. Bayer AG Cancer Therapy and Testing Product Offered
Table 113. Bayer AG Main Business
Table 114. Bayer AG Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Bayer AG Latest Developments
Table 116. Johnson & Johnson Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 117. Johnson & Johnson Cancer Therapy and Testing Product Offered
Table 118. Johnson & Johnson Main Business
Table 119. Johnson & Johnson Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Johnson & Johnson Latest Developments
Table 121. Pfizer Inc. Details, Company Type, Cancer Therapy and Testing Area Served and Its Competitors
Table 122. Pfizer Inc. Cancer Therapy and Testing Product Offered
Table 123. Pfizer Inc. Main Business
Table 124. Pfizer Inc. Cancer Therapy and Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Pfizer Inc. Latest Developments
List of

Figure 1. Cancer Therapy and Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Therapy and Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Therapy and Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Therapy and Testing Sales Market Share by Country/Region (2023)
Figure 8. Cancer Therapy and Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Therapy and Testing Market Size Market Share by Type in 2023
Figure 10. Cancer Therapy and Testing in Lung Cancer
Figure 11. Global Cancer Therapy and Testing Market: Lung Cancer (2019-2024) & ($ Millions)
Figure 12. Cancer Therapy and Testing in Rectal Cancer
Figure 13. Global Cancer Therapy and Testing Market: Rectal Cancer (2019-2024) & ($ Millions)
Figure 14. Cancer Therapy and Testing in Breast Cancer
Figure 15. Global Cancer Therapy and Testing Market: Breast Cancer (2019-2024) & ($ Millions)
Figure 16. Cancer Therapy and Testing in Other
Figure 17. Global Cancer Therapy and Testing Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Cancer Therapy and Testing Market Size Market Share by Application in 2023
Figure 19. Global Cancer Therapy and Testing Revenue Market Share by Player in 2023
Figure 20. Global Cancer Therapy and Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Cancer Therapy and Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Cancer Therapy and Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Cancer Therapy and Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Cancer Therapy and Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Cancer Therapy and Testing Value Market Share by Country in 2023
Figure 26. United States Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Cancer Therapy and Testing Market Size Market Share by Region in 2023
Figure 31. APAC Cancer Therapy and Testing Market Size Market Share by Type in 2023
Figure 32. APAC Cancer Therapy and Testing Market Size Market Share by Application in 2023
Figure 33. China Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Cancer Therapy and Testing Market Size Market Share by Country in 2023
Figure 40. Europe Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Cancer Therapy and Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Cancer Therapy and Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 63. China Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 67. India Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 70. France Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Cancer Therapy and Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global Cancer Therapy and Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Cancer Therapy and Testing Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted